Evaluation of Lamivudine Resistance Assay Using a Molecular Method in Patients with Chronic Hepatitis B
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.21, sa.1, ss.17-19, 2015 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 1
- Basım Tarihi: 2015
- Doi Numarası: 10.4274/vhd.42204
- Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.17-19
- Anahtar Kelimeler: Lamivudine, resistance, chronic hepatitis B
- Dokuz Eylül Üniversitesi Adresli: Hayır
Özet
Objective: Lamivudine is a nucleoside analogue approved by the FDA in 1998 for the treatment of chronic hepatitis B. Its unique disadvantage compared to other antiviral agents used in hepatitis B treatment is the emergence of drug resistance during treatment. In this study, we aimed to determine lamivudine resistant mutations.